Cadrenal Therapeutics, Inc. (CVKD)

NASDAQ: CVKD · IEX Real-Time Price · USD
0.640
+0.027 (4.40%)
Mar 27, 2024, 4:00 PM EDT - Market closed

Total Valuation

CVKD has a market cap or net worth of $9.77 million. The enterprise value is $1.38 million.

Market Cap 9.77M
Enterprise Value 1.38M

Important Dates

The last earnings date was Monday, March 11, 2024, before market open.

Earnings Date Mar 11, 2024
Ex-Dividend Date n/a

Share Statistics

CVKD has 13.02 million shares outstanding. The number of shares has increased by 70.99% in one year.

Shares Outstanding 13.02M
Shares Change (YoY) +70.99%
Shares Change (QoQ) +4.22%
Owned by Insiders (%) 47.04%
Owned by Institutions (%) 3.45%
Float 7.97M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 1.27
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 10.27, with a Debt / Equity ratio of 0.00.

Current Ratio 10.27
Quick Ratio n/a
Debt / Equity 0.00
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -487.69

Financial Efficiency

Return on equity (ROE) is -141.20% and return on invested capital (ROIC) is -98.95%.

Return on Equity (ROE) -141.20%
Return on Assets (ROA) -129.20%
Return on Capital (ROIC) -98.95%
Revenue Per Employee n/a
Profits Per Employee -$2.09M
Employee Count 4
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -50.79% in the last 52 weeks.

Beta (1Y) n/a
52-Week Price Change -50.79%
50-Day Moving Average 0.89
200-Day Moving Average 0.83
Relative Strength Index (RSI) 44.78
Average Volume (30 Days) 355,383

Short Selling Information

The latest short interest is 21,914, so 0.17% of the outstanding shares have been sold short.

Short Interest 21,914
Short Previous Month 7,168
Short % of Shares Out 0.17%
Short % of Float 0.27%
Short Ratio (days to cover) 0.01

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -7.63M
Pretax Income -8.36M
Net Income -8.36M
EBITDA -8.34M
EBIT -8.34M
Earnings Per Share (EPS) -$0.62
Full Income Statement

Balance Sheet

The company has $8.40 million in cash and $21,350 in debt, giving a net cash position of $8.38 million or $0.64 per share.

Cash & Cash Equivalents 8.40M
Total Debt 21,350
Net Cash 8.38M
Net Cash Per Share $0.64
Equity / Book Value 7.69M
Book Value Per Share 0.59
Working Capital 7.67M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$3.53 million and capital expenditures -$3,254, giving a free cash flow of -$3.53 million.

Operating Cash Flow -3.53M
Capital Expenditures -3,254
Free Cash Flow -3.53M
FCF Per Share -$0.26
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

CVKD does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -70.99%
Shareholder Yield -70.99%
Earnings Yield -85.58%
FCF Yield -36.19%

Analyst Forecast

The average price target for CVKD is $3.50, which is 446.88% higher than the current price. The consensus rating is "Strong Buy".

Price Target $3.50
Price Target Difference 446.88%
Analyst Consensus Strong Buy
Analyst Count 2
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) -1.98%
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2